Justices Make It Tougher to Sue Medical Device Makers
563525
The Supreme Court ruled that the manufacturer of a federally approved medical device cannot be sued under state law if the device causes an injury.
563444
The initiative is evidence that U.S. companies and universities are searching for ways to be less hampered by legal wrangling about who holds the patents to research.
77033
A decision to deny Alzheimer's drugs to patients with mild-stage disease is challenged at the High Court.
718979
The Supreme Court handed a victory  to Medtronic Inc  on Wednesday, ruling that patients  cannot sue medical-device manufacturers in state court over  harm from a device that has approval from federal regulators.
553996
The Supreme Court made it harder Thursday for most defendants to challenge their federal prison sentences.
241527
WASHINGTON -- The Supreme Court is about to plunge into an agenda laden with issues affecting the business sector. Tobacco companies, the biotech industry, and operators of coal-fired power plants have a stake in cases the court will hear in the next month.
174211
A drug manufacturer has been found to infringe patents licensed by the maker of a rival drug.
531191
Telecommunications giant AT&amp;T and Microsoft took a patent battle to the US Supreme Court Wednesday, in a case that has wide implications for US firms doing business abroad.
277649
Investors lost another round at the Supreme Court yesterday when the justices imposed a strict standard for shareholder lawsuits seeking to recover losses from companies accused of fraudulent business practices.
663443
By Julius A. Karash, The Kansas City Star, Mo.  Feb. 20--A recent ruling by the Kansas Supreme Court could open up health providers to a wider range of lawsuits.
564079
The U.S. technology industry has faced dozens of lawsuits by &quot;patent speculators&quot; in recent years, and it&#39;s time for Congress to fix problems with the patent system, Intel&#39;s general counsel said Monday.In the last 21 months, U.S. technology vendors have contended with 193 patent infringement lawsuits, and 70 percent of them came from patent speculators -- &quot;people who buy up patents for the purpose of litigating them,&quot; said Bruce Sewell, Intel&#39;s executive vice president and general counsel, at a patent forum.By contrast, companies in the pharmaceutical industry have been defendants in 28 patent infringement lawsuits during the same stretch, and 24 of those lawsuits have been between competitors, he said.Patent lawsuit reform is needed to fix the problem with patent speculators -- called patent trolls by some people -- Sewell said, speaking at a&#160;patent reform&#160;forum in Washington, D.C. Patent reform legislation pending in the U.S. Senate doesn&#39;t target legitimate inventors, he said.&quot;We&#39;re not talking about individual inventors who sue for patent infringement,&quot; Sewell said. &quot;We&#39;re talking about patent speculators who warehouse patents and use those patents to go after successful companies.&quot;But Hans Sauer, associated general counsel at the Biotechnology Industry Organization (BIO), called the Patent Reform Act, a version of which&#160;passed the House of Representatives&#160;in September, a &quot;very patent-hostile bill.&quot; In the Senate, the bill has&#160;stalled over objections&#160;from the biotech and pharmaceutical industries, as well as inventors and some labor unions.The House version of Patent Reform Act, supported by several large tech vendors including Microsoft and IBM, would allow courts to change the way they assess damages in patent infringement cases. Currently, courts generally consider the value of the entire product when a small piece of the product infringes a patent; the bill would allow courts to base damages only on the value of the infringing piece.&quot;Not all patents are identical,&quot; Sewell said. &quot;Some patents are more important in a product, and some patents are less important.&quot;The bill would also allow a new way to challenge patents within one year after they&#39;ve been granted.Changes in the way patents are enforced could hurt innovation, Sauer said. The bill could diminish incentives for the health industry to innovate in the coming years, he said.&quot;Will I, 30 years from now, pay $10 less for an iPod and have a 10 percent less chance that Alzheimer&#39;s medicine will be available?&quot; he said.It is difficult to predict the effects of the patent reform legislation, added Anat Hakim, a patent lawyer with Foley &amp; Lardner, the law firm that sponsored the patent forum.Sewell complained that there&#39;s a small &quot;cottage industry&quot; of patent speculators that have sprung up. &quot;The concern is that we don&#39;t end up encouraging another cottage industry,&quot; Hakim said.The U.S. Supreme Court has ruled on several patent questions in recent years, and the U.S. Patent and Trademark Office is instituting new rules later this year, Sauer noted. Adding a patent overhaul bill on top of those changes is &quot;a lot to happen at once,&quot; he said.But Sewell said the changes are needed for the IT industry, if not biotech. &quot;You have a group of companies that are happy with the status quo, and are saying, &#39;Don&#39;t change it; it&#39;s not broken,&#39;&quot; he said. &quot;That&#39;s fine, but it&#39;s broken for a lot of other people.&quot;
763506
Medical device maker Medtronic Inc. lost a patent case over heart stents against rivals Guidant Corp. and Boston Scientific Corp. on Wednesday, but the company said it would appeal the decision.
569663
The Florida Hospital Association has taken the lead in challenging two constitutional amendments that deal with medical errors and malpractice.
724080
The U.S. Supreme Court's decision in the LG Electronics and Quanta lawsuit will have an impact on patent holders' rights.
669199
WASHINGTON -- The Supreme Court on Monday refused to consider a lawsuit alleging two pharmaceutical companies conspired to monopolize the market for a drug used to treat breast cancer.
498778
The Supreme Court agreed to step into a dispute Friday over how far a patent can go to thwart a rival drug company's efforts to conduct research, a question with big-money ramifications in the pharmaceutical industry.
217472
Justices tried to estimate the harm of not regulating greenhouse gases from new vehicles.